COVID-19 Screening of Breast Cancer Patients During Treatment: A Single Center Experience in Japan.
Cancer Diagn Progn
; 1(5): 423-425, 2021.
Article
en En
| MEDLINE
| ID: mdl-35403168
ABSTRACT
Background/Aim:
Breast cancer treatment mainly involves interventional methods such as surgical resection and chemotherapy. How to best perform these treatments during the COVID-19 pandemic remains to be established. Patients andMethods:
Patients with breast cancer who received SARS-CoV-2 PCR screening before cancer treatment from December 2020 to April 2021 were included. PCR screening was performed within 72 hours of the scheduled admission time and treatment.Results:
A total of 19 tests in 15 patients were analysed. Fourteen cases displayed no symptoms, and five cases had some symptoms. COVID PCR tests were negative in all cases.Conclusion:
COVID-19 screening can ensure that breast cancer patients do not miss scheduled treatments as a result of the pandemic. Diagnosis of patients with symptoms that are shared by COVID-19 infection, chemotherapy, and breast cancer recurrence must be performed carefully.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Screening_studies
Idioma:
En
Revista:
Cancer Diagn Progn
Año:
2021
Tipo del documento:
Article
País de afiliación:
Japón